Brief No. 006 / Vol. 1
Distribution: Clients & Partners
Navco · Customs & Trade
Trade & Logistics Weekly Brief
U.S. Customs & Trade Developments for IORs, Maquiladoras & Trade Advisors
Bottom Line for Decision-Makers
The single biggest development of the past two weeks is enforcement, not tariffs. On July 31, DHS added 43 companies to the Uyghur Forced Labor Prevention Act (UFLPA) Entity List — the largest single expansion since the law’s 2021 enactment — taking the list from 144 to 187 entities effective August 3. There is no de minimis threshold: a single traceable input from any listed entity can detain an entire shipment, and clearing it requires clear-and-convincing evidence the goods are forced-labor-free. Separately, the 100% Section 232 pharmaceutical tariff took effect as scheduled on July 31 for the 17 companies named in Annex III, with the UK carved out to 0% under a bilateral agreement. On the North American front, Canada’s Section 338 50% tariff deadline (August 19) is now driving real negotiation — Prime Minister Carney described talks this week as “constructive,” and USTR has confirmed talks have not been cut off. The structural-overcapacity Section 301 investigation (16 economies, including Mexico and China) remains unresolved, and no ruling has issued in the Federal Circuit’s ongoing review of Section 122’s legality. Below: what moved, and what each reader should do about it.
Deadlines at a Glance
| Date | What happens |
|---|---|
| Jul 31 (occurred) | DHS announced 43 additions to the Uyghur Forced Labor Prevention Act (UFLPA) Entity List — largest-ever single expansion, 187 entities total. |
| Jul 31 (occurred) | 100% pharmaceutical Section 232 tariff took effect for Annex III companies; UK reduced to 0%. |
| Aug 3 (occurred) | UFLPA Entity List expansion took effect; rebuttable presumption now applies to the 43 new entities. |
| Aug 4 (occurred) | CBP’s court-ordered CAPE progress report filed with the Court of International Trade. |
| Aug 19 | Section 338 50% Canada tariff becomes effective absent a negotiated resolution. |
| Sep 29 | 100% pharmaceutical Section 232 tariff becomes effective for all remaining companies. |
| Sep (early) | USMCA Round 4, Washington, DC. |
Trade Updates
DHS adds 43 companies to the Uyghur Forced Labor Prevention Act (UFLPA) Entity List — the largest single expansion since 2021
On July 31, DHS, on behalf of the Forced Labor Enforcement Task Force, announced 43 additions to the Uyghur Forced Labor Prevention Act (UFLPA) Entity List, plus technical name updates to two existing entries. The revised list published as a Federal Register appendix on August 3 (FR Doc. 2026-15628) and took effect the same day, taking the list from 144 to 187 entities — a 30% increase and the single largest expansion since the UFLPA’s December 2021 enactment. The newly listed companies span five high-priority enforcement sectors: aluminum, apparel, copper, cotton, and tomatoes and their downstream products. DHS reports that CBP has denied entry to more than 24,300 shipments worth nearly $1 billion under the UFLPA since enactment.
The mechanics matter as much as the count: effective August 3, CBP applies the UFLPA’s rebuttable presumption to any goods from — or incorporating inputs from — a newly listed entity. There is no de minimis threshold; a single traceable input from any of the 187 listed entities can result in detention of an entire shipment. Clearing detained goods requires the importer to demonstrate by clear and convincing evidence that its supply chain is free of forced labor, a demanding standard with historically low approval rates. If your supply-chain mapping hasn’t been refreshed against the current list this week, that is the first thing to check.
Sources: DHS (Jul 31, 2026) · Federal Register (FR Doc. 2026-15628, Aug 3, 2026) · Thompson Hine
100% pharmaceutical tariff took effect July 31 as scheduled; UK carved out to 0%
Proclamation 11020’s Section 232 tariff on patented pharmaceuticals and active ingredients took effect July 31 for the 17 companies named in Annex III, confirmed in CBP guidance (CSMS #69395344, issued July 30). Generic pharmaceuticals, biosimilars, and orphan drugs remain excluded; companies with an approved U.S. onshoring plan and a signed MFN pricing agreement can qualify for reduced or 0% rates through January 2029. A second CBP notice (CSMS #69415934, August 1) confirmed a bilateral agreement reducing the rate on UK-origin patented pharmaceuticals and ingredients from 10% to 0%, also effective July 31. All other companies face the 100% rate starting September 29. Importers of Chapter 29 and 30 HTSUS products must report the applicable Chapter 99 classification (9903.04.60–9903.04.69) regardless of whether duty is currently owed.
Sources: CBP CSMS #69395344 (Jul 30, 2026) · CBP CSMS #69415934 (Aug 1, 2026) · The White House — Proclamation 11020 · Holland & Knight
Canada’s Section 338 deadline is now driving real negotiation ahead of August 19
With the 50% Section 338 tariff on select Canadian goods (dairy, alcohol, automobiles, and a broader list) set to take effect August 19, Prime Minister Mark Carney described U.S.–Canada talks this week as “quite firm” in tone but “constructive,” saying “we have real negotiations, constructive negotiations, on several issues.” USTR has confirmed talks have not been cut off. As previously reported, USMCA-qualifying goods get no exemption from Section 338 — a valid certificate of origin does not shield a covered product, unlike every other tariff track this year.
With less than two weeks remaining, importers with Canadian exposure should treat August 19 as a live deadline rather than a negotiating formality; Section 338 also carries no built-in expiration once in effect, unlike Section 122.
Sources: The White House (Fact Sheet, Jul 20, 2026) · Bloomberg
Structural overcapacity remains undetermined; Section 122 appeal has no ruling yet
The structural-overcapacity Section 301 investigation covering 16 economies — China, the EU, Japan, Korea, Vietnam, Taiwan, India, Mexico, and eight others — still has no published determination or proposed rates as of this issue, per USTR’s own program page. With the forced-labor track resolved, this remains the largest open item on the tariff docket, and both Mexico and China carry material exposure here alongside the other 14 named economies. Separately, the Federal Circuit has issued no ruling on the merits of Section 122’s legality since granting the government’s stay on June 11; the case (State of Oregon v. Trump, Nos. 2026-1804, 2026-1805) remains pending, and its outcome still governs refund rights for duties collected February 24–July 24.
Sources: USTR Section 301 Overcapacity Program Page · U.S. Court of Appeals for the Federal Circuit (docket, Nos. 2026-1804/-1805)
CBP filed its court-ordered CAPE progress report August 4
Per the Court of International Trade’s July 17 order, CBP filed a short progress report on CAPE Phase 3 development by the 5:00 p.m. ET August 4 deadline, with a closed settlement conference held August 5. As of CBP’s most recent public court declaration (July 10), cumulative figures stood at $166 billion in total IEEPA duties collected, $121.75 billion in claims accepted for CAPE processing, and $86.3 billion actually repaid to importers including interest. The July 17 order separately directs CBP to reliquidate certain finally-liquidated entries across roughly 3,700 pending cases once CAPE Phase 3 launches; the current lead case is Freestyle World, Inc. v. United States (1:26-cv-01088).
Sources: U.S. Court of International Trade (Order, Jul 17, 2026) · CBP (Declaration to the CIT, Jul 10, 2026)
EO 14411: still no proposed rule as the 90-day mark approaches
Nine weeks after signing (June 3), Executive Order 14411’s importer-of-record overhaul remains directional — no implementing proposed rule has published as of this issue. The 90-day mark (on or about September 1) is the next statutory checkpoint, covering the requirement that foreign exporters submit documentation filed with their home customs administration. The 180-day mark (November 30) covers the broader “good standing” requirement, minimum bonding thresholds, and IOR registry overhaul. Its core provisions remain unchanged: for formal entry, a foreign IOR must be CTPAT-validated where CBP deems it eligible, or file through a CTPAT-validated, licensed U.S. customs broker.
Sources: The White House — Executive Order 14411 (91 FR 35125) · Morrison Foerster
Takeaway for U.S. IORs
With no de minimis threshold, a single traceable input from any of the 43 newly listed entities can detain an entire shipment. If your compliance team hasn’t re-run supplier and sub-tier mapping against the list published August 3, that is the highest-priority action item this week — before a shipment gets held, not after.
If you import patented pharmaceuticals or active ingredients under HTSUS Chapters 29 or 30, confirm the correct Chapter 99 classification (9903.04.60–9903.04.69) is being reported on every entry regardless of whether duty is currently owed, and confirm whether your supplier’s Annex III status or UK-origin carve-out applies.
With talks described by Canada’s Prime Minister as “constructive” and USTR confirming negotiations remain active, there is a realistic chance the scope or timing shifts before August 19. Model your exposure under current terms while staying ready to adjust if a deal changes the picture in the next two weeks.
The Federal Circuit appeal over Section 122’s legality remains pending with no merits ruling since the June 11 stay. It still governs refund rights for duties collected February 24–July 24. With $86.3 billion in separate IEEPA refunds already repaid as of CBP’s last public figures, keep entry documentation and protests in order for both tracks.
Takeaway for Maquiladoras & Foreign IORs
The rebuttable presumption applies regardless of where final assembly happens; if Chinese-origin inputs from any newly listed entity flow into Mexico-assembled goods before reaching the U.S., that exposure travels with the product. Cross-check your upstream supplier list against the current 187-entity list, not just your direct Mexico-based vendors.
Mexico’s USMCA-qualifying goods remain shielded from the Section 301 forced-labor tariffs; Canadian goods get no such shield from the separate Section 338 action, regardless of USMCA qualification. Audit Canadian-origin exposure separately from Mexican-origin exposure — the two are no longer interchangeable under current rules, whatever the outcome of the next two weeks of negotiation.
Mexico is named among the 16 economies in the still-pending structural-overcapacity investigation, alongside China, the EU, Japan, Korea, and others. With the forced-labor track resolved and enforcement attention now on UFLPA expansion, this investigation is the next likely move from USTR — watch it specifically rather than treating recent developments as the end of the story.
No proposed rule has published yet, but the CTPAT-validation requirement for foreign IORs and the continuous-bond restriction remain the core provisions to prepare for. Review bonding, beneficial-ownership, and good-standing posture before the first implementation memo forces the issue.
Navco Trade Advisory & U.S. Customs Brokerage
Navco is a CTPAT-certified U.S. Customs broker (national permit), bonded warehouse and FTZ operator with 3PL and Fulfillment operations in Texas and partner network across the country. With the largest-ever UFLPA Entity List expansion now in effect and the Canada tariff deadline two weeks out, the levers below are where we help clients hold the line. (Commercial section — Navco advisory.)
Entity List screening & documentation support
We help clients cross-check supplier and sub-tier sourcing against the current 187-entity UFLPA list and assemble the clear-and-convincing-evidence documentation CBP requires to clear a detention — before a shipment gets held, not after.
CAPE compliance under the new warehouse-entry policy
With CAPE no longer accepting warehouse entries directly, we manage the corrected declaration-and-withdrawal sequencing needed to capture IEEPA refunds on affected entries, including those filed April 20–July 6 without a matching withdrawal.
Duty deferral through Fulfillment-from-Bond ahead of Aug 19
Stage Canadian-origin cargo in-bond ahead of the Section 338 effective date, reclassify against the covered-goods annexes, and time consumption entry deliberately. With USMCA offering no shield here, deferral and careful classification are your two real levers.
Protest filing & bond review
We preserve Section 122 refund rights for the Feb 24–Jul 24 collection period through disciplined protest filing and reconcile IEEPA claims via CAPE — while reviewing continuous-bond adequacy against the EO 14411 enforcement posture.
In-house Bonded & FTZ program design, certification, and management
Beyond our own bonded and FTZ facilities, Navco’s Trade & Logistics Advisory team reviews, designs, certifies, and manages in-bond and Foreign-Trade Zone programs directly at a client’s own location — manufacturing plants, distribution centers, retailer DCs, or 3PL warehouses. We have successfully implemented and managed these programs at client-owned sites across the country, giving importers the duty-deferral and compliance benefits of a bonded or FTZ operation without relocating inventory to a third-party facility. As EO 14411 raises the bar on bonded-custodian vetting and in-bond utilization, an audit-ready, Navco-certified in-house program is one of the most direct ways to stay ahead of the enforcement curve.
Sourcing standard. Every factual claim in this brief is sourced and dated. Sources are limited to: U.S. government (USTR, CBP, the Federal Register, Congress.gov, and other vetted agencies), Executive Orders, CBP CSMS, and analyses from named trade-law firms (Skadden, White & Case, Morrison Foerster, Diaz Trade Law, Braumiller Law, Brownstein, Holland & Knight, KPMG, Thompson Hine, and other vetted trade related firms and advisors), and Reuters, Bloomberg, CNBC, Financial Times, WSJ and other vetted news sources. Opinions, where offered, are labeled.
Disclaimer. This brief is informational and does not constitute legal advice or a customs ruling. Tariff treatment depends on facts specific to each entry. Confirm current rates, effective dates and eligibility against primary CBP and USTR sources before acting.
© 2026 Navco. Trade & Logistics Weekly Brief — Brief No. 006, issued August 7, 2026.